Dickran Kazandjian

13PUBLICATIONS
67CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsImmunogenetics (incl. genetic immunology)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 23, 2024
Genomic Profiling to Contextualize the Results of Intervention for Smoldering Multiple Myeloma.

Dickran Kazandjian, Benjamin Diamond, Marios Papadimitriou

|Jan 09, 2024
Genomic Classification and Individualized Prognosis in Multiple Myeloma.

Francesco Maura, Arjun Raj Rajanna, Bachisio Ziccheddu

|Jan 04, 2024
Emerging Strategies for the Prevention of Immune Toxicities Associated with T cell-Engaging Cancer Therapies.

Andrew Kowalski, Jill Lykon, Benjamin Diamond

|Nov 09, 2023
Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens.

Francesco Maura, Eileen M Boyle, David Coffey

|Sep 02, 2023
Immunophenotypic correlates of sustained MRD negativity in patients with multiple myeloma.

David G Coffey, Francesco Maura, Edgar Gonzalez-Kozlova

|Sep 01, 2023
MRD and Plasma Cell Dynamics after CAR T-cell Therapy in Myeloma.

Ola Landgren, Dickran Kazandjian

Pageof 3

Frequent Collaborators

11 joint publications

Ola Landgren

5 joint publications

Francesco Maura

5 joint publications

Benjamin Diamond

3 joint publications

Kylee Maclachlan